Marcus Cantillon
Chief Tech/Sci/R&D Officer presso Reviva Pharmaceuticals, Inc.
Patrimonio netto: 59 422 $ in data 31/03/2024
Profilo
Marcus Cantillon is currently the Chief Medical Officer at Reviva Pharmaceuticals, Inc. He previously worked as a Senior Director at AstraZeneca PLC from 1995 to 1997, as well as a Senior Director-Global Clinical Research at MPX Bioceutical ULC.
From 2006 to 2010, he was an Assistant Vice President at Merck & Co., Inc. He also served as the Chief Medical Officer at Reviva Pharmaceuticals Holdings, Inc. from 2020 to 2022.
Cantillon holds a doctorate degree from Karolinska Institutet.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 29/09/2023 | 15 720 ( 0.06% ) | 59 422 $ | 31/03/2024 |
Posizioni attive di Marcus Cantillon
| Società | Posizione | Inizio |
|---|---|---|
Reviva Pharmaceuticals, Inc.
 Reviva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reviva Pharmaceuticals, Inc. operates as a clinical stage development pharmaceutical company. The firm develops various therapies using chemical genomics for treatment of central nervous system, cardiovascular, metabolic and inflammatory diseases. The company was founded by Laxminarayan Bhat in 2006 and is headquartered in Cupertino, CA. | Chief Tech/Sci/R&D Officer | 01/01/2013 |
Precedenti posizioni note di Marcus Cantillon
| Società | Posizione | Fine |
|---|---|---|
| REVIVA PHARMACEUTICALS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 05/07/2022 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2010 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/01/1997 |
| MPX BIOCEUTICAL CORP | Chief Tech/Sci/R&D Officer | - |
Formazione di Marcus Cantillon
| Karolinska Institutet | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
MPX Bioceutical ULC
 MPX Bioceutical ULC Pharmaceuticals: MajorHealth Technology MPX Bioceutical Corp. engages in the provision of management, staffing, procurement, advisory, financial, real estate rental, logistics and administrative services. It offers financial and business assistance to emerging corporations, which includes pharmaceutical, medical and biotechnology industries. The company was founded on April 2, 1974 and is headquartered in Toronto, Canada. | Health Technology |
Reviva Pharmaceuticals, Inc.
Reviva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reviva Pharmaceuticals, Inc. operates as a clinical stage development pharmaceutical company. The firm develops various therapies using chemical genomics for treatment of central nervous system, cardiovascular, metabolic and inflammatory diseases. The company was founded by Laxminarayan Bhat in 2006 and is headquartered in Cupertino, CA. | Health Technology |
- Borsa valori
- Insiders
- Marcus Cantillon
